Hannover Rück SE (FRA:HNR1) Receives Consensus Recommendation of “Buy” from Brokerages

Hannover Rück SE (FRA:HNR1Get Rating) has earned a consensus recommendation of “N/A” from the thirteen brokerages that are presently covering the company, Marketbeat reports. The average 12 month price target among analysts that have covered the stock in the last year is €176.83 ($190.14).

Several equities analysts have commented on the stock. The Goldman Sachs Group set a €220.00 ($236.56) target price on shares of Hannover Rück in a research report on Thursday, February 10th. JPMorgan Chase & Co. set a €205.00 ($220.43) target price on shares of Hannover Rück in a research report on Thursday, April 14th. Morgan Stanley set a €179.00 ($192.47) target price on shares of Hannover Rück in a research report on Tuesday, April 5th. UBS Group set a €160.00 ($172.04) target price on shares of Hannover Rück in a research report on Monday. Finally, Berenberg Bank set a €197.00 ($211.83) target price on shares of Hannover Rück in a research report on Tuesday, April 19th.

Shares of FRA HNR1 opened at €145.00 ($155.91) on Tuesday. Hannover Rück has a fifty-two week low of €94.75 ($101.88) and a fifty-two week high of €116.37 ($125.13). The firm’s 50-day simple moving average is €153.41 and its 200 day simple moving average is €160.53.

Hannover Rück Company Profile (Get Rating)

Hannover Rück SE, together with its subsidiaries, provides reinsurance products and services worldwide. It operates through Property & Casualty Reinsurance, and Life & Health Reinsurance segments. The company offers property, casualty, facultative, catastrophe XL, structured reinsurance, and insurance-linked securities.

Recommended Stories

Analyst Recommendations for Hannover Rück (FRA:HNR1)

Receive News & Ratings for Hannover Rück Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hannover Rück and related companies with MarketBeat.com's FREE daily email newsletter.